CARDIOCOMMAND, INC.

CardioCommand Inc. is a leading medical technology innovator headquartered in Tampa, Florida, specializing in transesophageal (TAP) pacing and cardiac monitoring devices. Established in 1994, the company delivers minimally invasive cardiac solutions designed for clinicians in cardiology and anesthesia settings. CardioCommand's product portfolio includes transesophageal atrial pacing systems, esophageal catheters, electrode solutions, and noninvasive cardiac monitoring equipment. The company serves major academic medical centers, children's hospitals, and healthcare systems nationwide, supporting both diagnostic and therapeutic cardiac interventions including arrhythmia management, stress testing, and atrial cardioversion. Their TAP technology platform enables safe, easy-to-use cardiac assessment and management with minimal patient invasiveness.